Novel Substituted Cyclic Compounds as SLC6A19 Inhibitors for Treating Phenylketonuria and Other Amino Acidurias.

Provided herein are novel substituted cyclic compounds as SLC6A19 inhibitors, pharmaceutical compositions, use of such compounds in treating phenylketonuria, and other amino acidurias and processes for preparing such compounds.